Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goi Sakamoto

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Surgery Today|August 1, 2008
Primary small-cell neuroendocrine carcinoma of the breast: report of a caseSatoki Kinoshita, Akio Hirano, Kazumasa Komine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapyNaoko Honma, Rie Horii, Takuji Iwase, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Indications and limits of breast conserving treatment]Kaoru Takahashi, Seiichiro Nishimura, Keiichiro Tada, et al.
Journal of Cancer Research and Clinical Oncology|December 14, 2007
Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trialMasafumi Kurosumi, Yuichi Takatsuka, Toru Watanabe, et al.
Breast Cancer (Tokyo, Japan)|March 5, 2009
Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a caseSatoki Kinoshita, Akio Hirano, Susumu Kobayashi, et al.
American Journal of Clinical Pathology|November 21, 2008
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standardShinobu Umemura, R Yoshiyuki Osamura, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|August 28, 2002
Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell linesFumie Matsuo, Ken-ichi Yano, Hiroko Saito, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2004
What is the predictor for invasion in non-palpable breast cancer with microcalcifications?Seiichiro Nishimura, Kaoru Takahashi, Naoya Gomi, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosisSeiichiro Nishimura, Kaoru Takahashi, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|August 11, 2007
Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 yearsTomo Osako, Takuji Iwase, Kaoru Takahashi, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Surgery Today|August 1, 2008
Primary small-cell neuroendocrine carcinoma of the breast: report of a caseSatoki Kinoshita, Akio Hirano, Kazumasa Komine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapyNaoko Honma, Rie Horii, Takuji Iwase, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Indications and limits of breast conserving treatment]Kaoru Takahashi, Seiichiro Nishimura, Keiichiro Tada, et al.
Journal of Cancer Research and Clinical Oncology|December 14, 2007
Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trialMasafumi Kurosumi, Yuichi Takatsuka, Toru Watanabe, et al.
Breast Cancer (Tokyo, Japan)|March 5, 2009
Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a caseSatoki Kinoshita, Akio Hirano, Susumu Kobayashi, et al.
American Journal of Clinical Pathology|November 21, 2008
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standardShinobu Umemura, R Yoshiyuki Osamura, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|August 28, 2002
Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell linesFumie Matsuo, Ken-ichi Yano, Hiroko Saito, et al.
Breast Cancer (Tokyo, Japan)|January 14, 2004
What is the predictor for invasion in non-palpable breast cancer with microcalcifications?Seiichiro Nishimura, Kaoru Takahashi, Naoya Gomi, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosisSeiichiro Nishimura, Kaoru Takahashi, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|August 11, 2007
Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 yearsTomo Osako, Takuji Iwase, Kaoru Takahashi, et al.
Pageof 6